Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT05128955 · ClinicalTrials.gov registry record · NA
Embolization of the Splenic Artery After Trauma
A NA study of High-grade Splenic Injuries, sponsored by Andrew J. Gunn.
- Recruiting
- Registry status
- NA
- Development phase
- 250
- Enrollment target
- 5
- Study locations
NCT05128955 is a NA study of High-grade Splenic Injuries that is actively recruiting participants, run by Andrew J. Gunn. The registered enrollment target is 250 participants. The trial reports 5 study locations across 5 states.
The verdict
NCT05128955, a NA study of High-grade Splenic Injuries, is actively recruiting participants, sponsored by Andrew J. Gunn.
- RECRUITING
- Registry status
- NA
- Development phase
- 250 participants
- Enrollment target
- 5
- Study locations
Study Summary
Our aim is to conduct a multi-center, Bayesian, randomized clinical trial to evaluate the primary technical success of coils and vascular plugs for proximal splenic artery embolization in the setting of high-grade splenic trauma. The investigator has previously demonstrated the feasibility of such a study in a single center pilot trial.
Conditions Studied
Interventions
- DEVICE Splenic artery embolization with vascular embolic coils or plugs
Study Locations (5)
Alabama
- University of Alabama at Birmingham - Birmingham
North Carolina
- Wake Forest Baptist Medical Center - Winston-Salem
Ohio
- Ohio State University Medical Center - Columbus
South Carolina
- Prisma Health - Greenville
Texas
- The University of Texas Health Science Center at Houston McGovern Medical School - Houston
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 250 participants |
| Start Date | 2022-05-10 |
| Est. Completion | 2026-12 |
| Phase | NA |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT05128955
The ClinicalTrials.gov registry entry for NCT05128955 describes a study currently listed as recruiting, categorized as NA. The registered enrollment target is 250 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is Andrew J. Gunn, which has 1 total studies on file at ClinicalTrials.gov.
The record links to 1 condition, with High-grade Splenic Injuries appearing as the primary indexed condition, and to 1 intervention - of which Splenic artery embolization with vascular embolic coils or plugs is the first listed.
NCT05128955 reports 5 study locations spanning 5 distinct geographic areas - top geographies include Alabama, North Carolina, Ohio.
Frequently Asked Questions
What is clinical trial NCT05128955 about?
NCT05128955 is a clinical study titled "Embolization of the Splenic Artery After Trauma". Our aim is to conduct a multi-center, Bayesian, randomized clinical trial to evaluate the primary technical success of coils and vascular plugs for proximal splenic artery embolization in the setting of high-grade splenic trauma. The investigator has previously demonstrated the feasibility of such a...
What is the current status of trial NCT05128955?
This trial is currently recruiting. It is a NA study. The enrollment target is 250 participants. The study started on 2022-05-10. Estimated completion is 2026-12.
What conditions does trial NCT05128955 study?
This clinical trial studies the following conditions: High-grade Splenic Injuries.
What interventions are being tested in trial NCT05128955?
The interventions under investigation include: Splenic artery embolization with vascular embolic coils or plugs (DEVICE).
Who is sponsoring clinical trial NCT05128955?
This trial is sponsored by Andrew J. Gunn, which has 1 total clinical trials registered on ClinicalTrials.gov.
Where is trial NCT05128955 being conducted?
This trial has 5 study locations across Alabama, North Carolina, Ohio, South Carolina, Texas. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.
Learn More About Clinical Trials
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.